rezolute 01162025 #Art #DCSpensley #Digitalabstract #Eyecandy #DanCoyote #glitch #digitalcollage #neverai #freethepixels #collage #remix #Artwork #Artists #BskyArt #SkyArt #FineArt #AbstractArt
January 17, 2025 at 7:36 AM
November 10, 2024 at 12:11 AM
#RZLT Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
https://www.stocktitan.net/news/RZLT/rezolute-reports-fourth-quarter-and-full-year-fiscal-2026-financial-5opg3xakvbzs.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/RZLT/rezolute-reports-fourth-quarter-and-full-year-fiscal-2026-financial-5opg3xakvbzs.html?utm_source=stocktitan-bluesky&utm_medium=social
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 24, 2026 at 8:05 PM
#RZLT Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
https://www.stocktitan.net/news/RZLT/rezolute-reports-fourth-quarter-and-full-year-fiscal-2026-financial-5opg3xakvbzs.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/RZLT/rezolute-reports-fourth-quarter-and-full-year-fiscal-2026-financial-5opg3xakvbzs.html?utm_source=stocktitan-bluesky&utm_medium=social
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
November 10, 2025 at 10:39 PM
#Rezolute is proud to support Neuroendocrine Cancer Awareness Day! Neuroendocrine tumors (NETs) can have a profound impact on patients’ lives, so join us in raising awareness and supporting those affected by NET cancers.
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
#LetsTalkAboutNETs #NETCancerDay #tumorhyperinsulinism #OncSky #EndoSky #MedSky
🎗️ Today June 7th is Global Hyperinsulinism Awareness Day 🎗️Rezolute proudly stands with the incredible HI advocacy community who inspire our work every day.
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
June 7, 2025 at 7:10 AM
🎗️ Today June 7th is Global Hyperinsulinism Awareness Day 🎗️Rezolute proudly stands with the incredible HI advocacy community who inspire our work every day.
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
@chcharityuk.bsky.social
#GlobalHIAwarenessDay #HyperinsulinismAwareness #AimHI #congenitalHI #CHCUK #RareDisease #RZLTCaresAboutRare (1/3)
Rezolute is proud to join Bluesky! As a rare disease biotech, we’re committed to advancing a potential therapy for patients with hyperinsulinism and fostering transparent, meaningful conversations in the rare disease space. Follow along as we share updates, education, and advocacy highlights!
June 5, 2025 at 10:25 PM
Rezolute is proud to join Bluesky! As a rare disease biotech, we’re committed to advancing a potential therapy for patients with hyperinsulinism and fostering transparent, meaningful conversations in the rare disease space. Follow along as we share updates, education, and advocacy highlights!
November is #NationalFamilyCaregiversMonth, a time to honor and celebrate the incredible #caregivers who provide invaluable support to the #hyperinsulinism community.
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
November 26, 2025 at 8:42 PM
November is #NationalFamilyCaregiversMonth, a time to honor and celebrate the incredible #caregivers who provide invaluable support to the #hyperinsulinism community.
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Hear more from caregivers here: bit.ly/46IK51G
#Rezolute #congenitalHI #tumorhyperinsulinism #raredisease #MedSky #EndoSky #PedSky
Rezolute Reports Widening Net Loss Amid Pivotal Clinical Readouts for Ersodetug: Rezolute's net loss grew to $77.6 million for fiscal 2026 as G&A costs rose sharply ahead of potential commercialization, while the company navigates a critical FDA regulatory review… #Sec10K Follow Us for more
Rezolute Reports Widening Net Loss Amid Pivotal Clinical Readouts for Ersodetug
Rezolute's net loss grew to $77.6 million for fiscal 2026 as G&A costs rose sharply ahead of potential commercialization, while the company navigates a critical FDA regulatory review following mixed Phase 3 trial results.
quantli.com
September 24, 2026 at 8:35 PM
Rezolute Reports Widening Net Loss Amid Pivotal Clinical Readouts for Ersodetug: Rezolute's net loss grew to $77.6 million for fiscal 2026 as G&A costs rose sharply ahead of potential commercialization, while the company navigates a critical FDA regulatory review… #Sec10K Follow Us for more
Rama në OKB përgatit rezolutë për mbrojtjen e homoseksualëve
26 Shtator 2026 Edi Rama zhgënjeu opinionin publik në Kosovë pas fjalimit të mbajtur në OKB. Ai nuk tha asnjë fjalë për Kosovën, aq më pak për dënimin e ish-krerëve të UÇK. Në vend të kësaj, përpar…
www.shqiperia.com
September 26, 2026 at 10:27 AM
$RZLT - Rezolute
An unexpected article in Yahoo Finance :
"Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025 ?"
Well, RZLT has been a multibagger for all who bought it when I did, but the "best" for 2025 !!??
Judge for yourself.
ca.finance.yahoo.com/news/rezolut...
An unexpected article in Yahoo Finance :
"Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025 ?"
Well, RZLT has been a multibagger for all who bought it when I did, but the "best" for 2025 !!??
Judge for yourself.
ca.finance.yahoo.com/news/rezolut...
Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025?
We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a look at where Rezolute, Inc. (NASDAQ:RZLT) stands against other best multib...
ca.finance.yahoo.com
November 21, 2024 at 12:04 AM
$RZLT - Rezolute
An unexpected article in Yahoo Finance :
"Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025 ?"
Well, RZLT has been a multibagger for all who bought it when I did, but the "best" for 2025 !!??
Judge for yourself.
ca.finance.yahoo.com/news/rezolut...
An unexpected article in Yahoo Finance :
"Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025 ?"
Well, RZLT has been a multibagger for all who bought it when I did, but the "best" for 2025 !!??
Judge for yourself.
ca.finance.yahoo.com/news/rezolut...
Nënkryetari i Aleancës kërkon mbledhjen urgjente të Kuvendit për të miratuar një rezolutë pas vendimit të Dhomave të Specializuara ndaj çlirimtarëve të UÇK-së.
Besnik Tahiri kërkon rezolutë të Kuvendit për vendimin e Hagës
Temë e gjallë Verdikti i Hagës për ish-krerët e UÇK-sëTë gjitha zhvillimet, në një faqe që përditësohet.
Nënkryetari i Aleancës, Besnik Tahiri, ka kërkuar nga Kuvendi i Kosovës që të mblidhet urgjentisht dhe të miratojë një rezolutë lidhur me vendimin e Dhomave të Specializuara në Hagë ndaj katër çlirimtarëve të Ushtrisë Çlirimtare të Kosovës, Hashim Thaçit, Kadri Veselit, Rexhep Selimit dhe Jakup Krasniqit. Kjo kërkesë vjen pas vendimit të mëparshëm të kësaj gjykate ndaj katër krerëve të UÇK-së, ndërsa tani theksi vihet te mungesa e një qëndrimi institucional nga ana e Kuvendit të Kosovës.
Video · Facebook ↗
Tahiri ka kritikuar faktin se ka kaluar një javë prej kur Dhomat e Specializuara në Hagë kanë marrë një vendim dënues ndaj katër çlirimtarëve, ndërsa Kuvendi ende nuk ka shprehur një qëndrim politik, institucional apo shtetëror përmes një rezolute që e dënon dhe që thërret për drejtësi, duke adresuar çështjet që janë konsideruar shumë problematike në atë vendim. Ai ka theksuar se «heshtja dhe kalkulimi politik nuk është dhe nuk duhet të jetë politikë ditore».
Sipas tij, është urgjente që Kuvendi i Republikës së Kosovës të mblidhet dhe të ketë një qëndrim politik dhe një rezolutë për të drejtën dhe për historinë e vendit. Ai ka shtuar se qëndrimi i Kuvendit do të vlerësohet edhe nga gjeneratat e ardhshme, duke kujtuar se tregimi i luftës për liri është tregimi më i shenjtë dhe se UÇK-ja është vlera më e madhe kombëtare.
Në thirrjen e tij për deputetët, ai ka kërkuar që politika ditore dhe kalkulimet politike të lihen anash, duke bërë thirrje që të bashkohen dhe të mblidhen sa më shpejt, pasi bëhet fjalë për një histori që kërkon përgjegjësi institucionale pa vonesa shtesë.
**Burimet:** Zhurnal.mk; Epoka e Re; Telegrafi; Veriu.info; Gazeta Metro (klaster 8 outlets).
zhurma.press
September 23, 2026 at 11:48 AM
Nënkryetari i Aleancës kërkon mbledhjen urgjente të Kuvendit për të miratuar një rezolutë pas vendimit të Dhomave të Specializuara ndaj çlirimtarëve të UÇK-së.
Meeting Sarah Dearman at the Children’s Hyperinsulinism Charity conference and learning about the charity’s work was inspiring. It was great to connect face to face with Davelyn Hood from Rezolute. Ersodetug offers real hope for better care, and I am excited about future collaboration #insulinoma
July 30, 2025 at 8:10 PM
Meeting Sarah Dearman at the Children’s Hyperinsulinism Charity conference and learning about the charity’s work was inspiring. It was great to connect face to face with Davelyn Hood from Rezolute. Ersodetug offers real hope for better care, and I am excited about future collaboration #insulinoma
News; ( NASDAQ: #RZLT ) Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
#StockMarket #News
#StockMarket #News
August 5, 2024 at 4:55 PM
💙 For Global Hyperinsulinism Awareness Day, Rezolute proudly stands with the whole congenital hyperinsulinism (HI) community and supports the incredible work of Congenital Hyperinsulinism International (CHI) in raising awareness for hypoglycemia caused by HI. (2/3)
June 6, 2025 at 4:22 PM
💙 For Global Hyperinsulinism Awareness Day, Rezolute proudly stands with the whole congenital hyperinsulinism (HI) community and supports the incredible work of Congenital Hyperinsulinism International (CHI) in raising awareness for hypoglycemia caused by HI. (2/3)
1920 ZPB 🕊️😼
Lambda Rho - Spr 14 - Ace C1ub/Rock Club (4 in 3 out)
Ship Name : The Answer
Line Name: ReZolute
Lambda Rho - Spr 14 - Ace C1ub/Rock Club (4 in 3 out)
Ship Name : The Answer
Line Name: ReZolute
November 15, 2024 at 5:40 PM
1920 ZPB 🕊️😼
Lambda Rho - Spr 14 - Ace C1ub/Rock Club (4 in 3 out)
Ship Name : The Answer
Line Name: ReZolute
Lambda Rho - Spr 14 - Ace C1ub/Rock Club (4 in 3 out)
Ship Name : The Answer
Line Name: ReZolute
🚨 $RZLT
On September 24, 2026, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including Exhibit ...
On September 24, 2026, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including Exhibit ...
SEC Filing: RZLT
Click to view the official SEC document.
www.sec.gov
September 24, 2026 at 8:27 PM
🚨 $RZLT
On September 24, 2026, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including Exhibit ...
On September 24, 2026, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2026. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including Exhibit ...
What a weekend for #Rezolute Medical Affairs! 🌍 Our team proudly represented at #ASPED2025 (Dubai), #SCOPE (Long Beach), and #AAP2025 (Denver)—sharing insights on congenital hyperinsulinism and ersodetug (RZ358). Grateful to all who engaged with us! #RZLT #ersodetug #EndoSky #RZLTMedAffairsInAction
September 30, 2025 at 10:18 PM
What a weekend for #Rezolute Medical Affairs! 🌍 Our team proudly represented at #ASPED2025 (Dubai), #SCOPE (Long Beach), and #AAP2025 (Denver)—sharing insights on congenital hyperinsulinism and ersodetug (RZ358). Grateful to all who engaged with us! #RZLT #ersodetug #EndoSky #RZLTMedAffairsInAction
We were honored to attend the UKI NETS Annual Conference yesterday and connect with leading experts and people impacted by #insulinomas, a rare type of neuroendocrine tumor.
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
December 5, 2025 at 10:05 AM
We were honored to attend the UKI NETS Annual Conference yesterday and connect with leading experts and people impacted by #insulinomas, a rare type of neuroendocrine tumor.
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
At Rezolute, we’re committed to advancing care options for the #hyperinsulinism
#MedSky #EndoSky #OncSky #raredisease
December 16, 2025 at 12:35 AM
#RZLT Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
https://www.stocktitan.net/news/RZLT/rezolute-provides-update-on-its-congenital-hyperinsulinism-program-315rljm1f491.html
https://www.stocktitan.net/news/RZLT/rezolute-provides-update-on-its-congenital-hyperinsulinism-program-315rljm1f491.html
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
Rezolute (Nasdaq: RZLT) reported outcomes from an FDA Type B meeting on March 17, 2026, for sunRIZE, a Phase 3 ersodetug study for congenital hyperinsulinism. The pivotal trial did not meet its primary endpoint versus placebo, though consistent CGM-based improvements and pharmacologic activity were observed.FDA encouraged submission of full study reports and datasets for independent review and did not dismiss the program; Rezolute expects an update in the second half of 2026.
www.stocktitan.net
March 24, 2026 at 11:00 AM
#RZLT Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
https://www.stocktitan.net/news/RZLT/rezolute-provides-update-on-its-congenital-hyperinsulinism-program-315rljm1f491.html
https://www.stocktitan.net/news/RZLT/rezolute-provides-update-on-its-congenital-hyperinsulinism-program-315rljm1f491.html
Congenital Hyperinsulinism Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rezolute, Hanmi Pharma, Zealand Pharma, Crinetics Pharma
Congenital Hyperinsulinism Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rezolute, Hanmi Pharma, Zealand Pharma, Crinetics Pharma – PressReleaseCC
Congenital Hyperinsulinism Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rezolute, Hanmi Pharma, Zealand Pharma, Crinetics Pharma
www.pressreleasecc.com
January 2, 2026 at 8:12 AM
Congenital Hyperinsulinism Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Rezolute, Hanmi Pharma, Zealand Pharma, Crinetics Pharma
#RZLT Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
https://www.stocktitan.net/news/RZLT/rezolute-announces-completion-of-enrollment-in-the-phase-3-sun-rize-b071ohercbx1.html
https://www.stocktitan.net/news/RZLT/rezolute-announces-completion-of-enrollment-in-the-phase-3-sun-rize-b071ohercbx1.html
Rezolute Completes Phase 3 Enrollment for Breakthrough Rare Disease Drug - 62 Patients to Reveal Results by December
Phase 3 sunRIZE study exceeds target with 62 patients enrolled. Learn when topline data for this potential breakthrough in congenital hyperinsulinism treatment arrives. Get Timeline
www.stocktitan.net
May 28, 2025 at 12:00 PM
#RZLT Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
https://www.stocktitan.net/news/RZLT/rezolute-announces-completion-of-enrollment-in-the-phase-3-sun-rize-b071ohercbx1.html
https://www.stocktitan.net/news/RZLT/rezolute-announces-completion-of-enrollment-in-the-phase-3-sun-rize-b071ohercbx1.html
As patients navigate life with #hyperinsulinism, #Rezolute Patient Affairs team is committed to walking alongside them every step of the way. That’s why we are excited to launch 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯, a new initiative dedicated to supporting those impacted by hypoglycemia related to hyperinsulinism
December 5, 2025 at 10:10 AM
As patients navigate life with #hyperinsulinism, #Rezolute Patient Affairs team is committed to walking alongside them every step of the way. That’s why we are excited to launch 𝘛𝘩𝘦 𝘙𝘦𝘻𝘰𝘭𝘶𝘵𝘪𝘰𝘯, a new initiative dedicated to supporting those impacted by hypoglycemia related to hyperinsulinism